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Background Contrast induced nephrotoxicity (CIN) after coronary angiog-
raphy or angioplasty (CA) has been shown to be related to mortality. The rate and
predictors of CIN when preventive measures are applied are poorly documented.
Methods All consecutive patients submitted to non-urgent CA in 2014 with
low-osmolar contrast medium were stratified for CIN risk: patients with renal
dysfunction (defined as eGFR<60mL/min) had interruption of diuretics and
received a 250-500mL intravenous saline infusion before and after CA. Serum
Creatinine (SCr) levels were measured before CA and daily thereafter up to 5
days after CA. CIN was defined as an absolute increase of 44 μmol/L SCr or
of 25% over baseline SCr level. Predictors of CIN and of recovery were deter-
mined by logistic regression. CIN patients had clinical follow-up for death or
end-stage renal dysfunction.
Results SCr results were available in 958 patients, 72% male, 25% dia-
betics, median eGFR was 71mL/min before CA (interquartiles (IQ) =54; 89).
Median amount of contrast was 129mL (IQ=90; 186). At 2-4 days, CIN was
observed in 188(20%), driven by a 25% increase in SCr (n=185, 19%)
whereas 81 (8.5%) had an increase of >44mmol/L in SCr. CIN rate was
related to quartiles of eGFR before CA: 20% when eGFR<53, 14% for eGFR
between 53 and 88 and 30% for eGFR>87ml/min. The amount of contrast
medium was not a predictor of CIN. In patients without renal dysfunction, a
lower SCr was a predictor of CIN. Conversely, in patients with renal dysfunc-
tion, older age and diabetes were associated with CIN (figure).
Conclusions In contemporary routine practice, CIN occurs in 20%, driven
by a relative 25% increase in SCr, and irrespective of the amount of contrast
medium. In patients with renal dysfunction, older age and diabetes were asso-
ciated with CIN.
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Background Early infarct-related artery (IRA) patency is associated with
better clinical outcomes in STEMI patients. Using the FAST-MI 2010 ST-ele-
vation myocardial infarction (STEMI) cohort, we investigated factors related
to IRA patency (TIMI 2/3 flow) at the start of procedure in patients admitted
for primary percutaneous coronary intervention (PCI).
Methods and results FAST-MI 2010 is a nationwide French registry
including 4,169 Acute MI patients. Of 1452 STEMI patients with primary
PCI, 466 (32%) had TIMI 2/3 flow of IRA before the procedure. Mean age
(62±14 years in both groups), GRACE score (141±31 vs 142±34) and time
from onset to angiography (472±499 vs 451±479min) did not differ according
to IRA patency (TIMI2/3 vs TIMI 0/1). Using multivariate logistic regression
analysis, IRA patency was more frequently found in patients having called
earlier (<75min, median time from symptom onset: OR: 1.60; 95% CI 1.26-
2.04), or receiving antiplatelet therapy (APT) before angiography. Increasing
time from diagnostic ECG to angiography was also associated with IRA
patency (>90min, OR: 1,38; 95%IC 1.08-1.77). The results were confirmed by
propensity score analyses.
Conclusion Pre-procedural IRA patency is observed in one third of STEMI
patients; it is more frequently found in patients having received APT prior to
angiography, as well as in patients having called early. Higher IRA patency
with increasing time delays from qualifying ECG to angiography suggests an
additional role of spontaneous or medication-mediated fibrinolysis.
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